Literature DB >> 28405089

Right hemispheric reversible cerebral vasoconstriction syndrome in a patient with left hemispheric partial seizures.

Gina S Perez1, Justin McCaslin1, Sadat Shamim1.   

Abstract

We report a right-handed 19-year-old girl who developed reversible cerebral vasoconstriction syndrome (RCVS) lateralized to the right hemisphere with simultaneous new-onset left hemispheric seizures. RCVS, typically more diffuse, was lateralized to one of the cerebral hemispheres.

Entities:  

Year:  2017        PMID： 28405089      PMCID： PMC5349835          DOI： 10.1080/08998280.2017.11929593

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  7 in total

1.  Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Derek M Sorensen
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

Review 2.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

3.  Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Kenneth R L Bernard; Morris Rivera
Journal:  J Emerg Med       Date:  2015-04-07       Impact factor: 1.484

Review 4.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

Review 5.  Reversible cerebral vasoconstriction syndrome: a comprehensive update.

Authors:  Ali Mehdi; Rula A Hajj-Ali
Journal:  Curr Pain Headache Rep       Date:  2014-09

6.  Diffuse cerebrovascular dilation: Case report of amezinium metilsulfate-induced reversible cerebral vasoconstriction syndrome.

Authors:  Makoto Kobayashi
Journal:  Cephalalgia       Date:  2015-05-27       Impact factor: 6.292

7.  Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome.

Authors:  Mehmet Akif Topcuoglu; Suk-Tak Chan; Gisele Sampaio Silva; Eric Edward Smith; Kenneth K Kwong; Aneesh Bhim Singhal
Journal:  Cephalalgia       Date:  2016-05-20       Impact factor: 6.292
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.